Comparison of the Effectiveness of Rocuronium - Sugammadex With Succinylcholine-Cisatracurium-Pyridostigmine in Patients Undergoing Laser Microlaryngeal Surgery

Trial Profile

Comparison of the Effectiveness of Rocuronium - Sugammadex With Succinylcholine-Cisatracurium-Pyridostigmine in Patients Undergoing Laser Microlaryngeal Surgery

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Sugammadex (Primary) ; Cisatracurium besilate; Fentanyl; Neostigmine; Rocuronium bromide
  • Indications Muscle injury; Muscle pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2015 Planned End Date changed from 1 Feb 2016 to 1 Sep 2016 as per ClinicalTrials.gov record.
    • 27 Sep 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 06 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top